Parametrica Management LTD Nektar Therapeutics Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $215,386 - $259,911	-13,658 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $226,586 - $338,581	13,658 New	13,658 $226,000
Q1 2018 Apr 24, 2018	SELL	$57.4 - $108.44 $447,031 - $844,530	-7,788 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$23.02 - $60.5 $179,279 - $471,174	7,788	7,788 $465,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.